A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines
about
Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years oldEvaluation of the Families SHARE workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer.Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC)A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiencyMicrosatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastasesCarcinogenesis and microsatellite instability: the interrelationship between genetics and epigeneticsDevelopment and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy.Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancerInvestigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer.Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer.Colorectal cancer: molecules and populations.Survey of HNPCC Management Analysis of Responses from 18 International Cancer Centres.Hereditary colorectal cancer in chinaOrganization and running of the first comprehensive hereditary cancer clinic in India.Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer.Genetic testing and counseling for hereditary forms of colorectal cancer.Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at 'BAT 25' and 'BAT 26' microsatellite markers in early-onset breast cancer.Distinct clinical features associated with microsatellite instability in colorectal cancers of young patients.Hereditary colorectal cancer: risk assessment and management.The mutational spectrum of Lynch syndrome in cyprus.Application of molecular diagnostics for the detection of Lynch syndrome.Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countriesChemoprevention in patients with genetic risk of colorectal cancersClinicopathological and genetic features of Chinese hereditary nonpolyposis colorectal cancer (HNPCC).Medical-legal risks of incident cancers after clearing colonoscopy.Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer.The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics programHigh incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study.Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateGermline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer.MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular featuresComparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer.Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome.Review article: genetic testing and counselling for hereditary colorectal cancer.Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer.
P2860
Q21256711-E63988F1-87B6-40D8-B934-8D02A25C5946Q27310710-923A0BB8-7A3B-4CB6-924B-172A6946FDD3Q28085485-8F37912C-4F2B-40A4-BC3A-F7B7168424F9Q28202312-9B0B6DB5-2A3D-496B-A75E-57C6DE292CECQ28217427-A749C963-3712-4305-97ED-F987E71A1383Q28247135-DF9C3728-1D96-4122-8CF1-3D454ACC9684Q28253670-3F3EE8FA-5981-47C9-80FA-41F36E10A4F0Q30484158-0526BC12-0C93-4920-91ED-C6BCB5E7D8EAQ30906288-B67F9417-05B3-4755-BE1E-DDFBBA9E714CQ33318711-9D07A01A-6D4A-4E99-A0CF-73313CB1AB72Q33511546-E372CEF6-E4C5-4C29-BDA7-5E96C8737ABFQ33550512-9D41A5F9-D566-4336-93CD-3FDF220A1CE5Q33652932-96A727EF-EB28-4C19-BC99-DE3035A44B12Q33721542-90C05EDD-2271-4311-AC88-3F7CA5441F78Q33721553-CC610C18-78FE-4DDA-8EEF-631628BD23A2Q33721559-652BD865-A45B-40AB-BEC2-1C3620B83A82Q33775296-0CEB1827-13FC-4549-988E-2B99CB1A5E05Q33813997-DE64654E-5B63-4F25-98B6-570F379921B5Q33814001-1DCFB6BD-068E-4271-9F5D-2B82F4617EE8Q33866105-3DA6EAEA-46A5-491A-9640-3E739304321BQ33938926-0244BB69-91BB-493E-9F0E-AAC3070E78ACQ34012713-8C7FD566-A809-4EAF-9946-24AE5C695224Q34045183-88AA8F03-FE55-4CB7-954E-AD94F7057A51Q34062115-A1FA42A0-AEB0-40B9-A496-BC6020686B4EQ34088809-84F22989-D504-47C1-847C-36D9EFC59715Q34155518-F48BF428-EF1E-4BCD-BF44-46D8E1978F57Q34170508-FD8F9CEC-856D-400F-B633-3DD50046011AQ34174654-8C8D3863-8C91-4B3B-BFF5-188ACCD2954DQ34227847-43B167E8-34A9-4D1F-8109-ECF80040C718Q34247085-F30182BF-BC27-4E2A-9AC3-17C024C20221Q34380045-AFDCC4CA-2A06-4B21-B954-65109F1EAEC9Q34396531-360741CD-C153-44ED-801C-0430364A83BCQ34422005-EA5EC16D-233E-407F-80A1-A2F97F1B317AQ34441837-98DCD802-E915-4283-8C97-883CA6FEAB44Q34481263-69116D3E-5AC1-4D27-B5A2-D850C9E1AD97Q34650716-02F17C2F-15CC-4284-B307-CE87E1F2FAF8Q34779174-B04C2742-3501-4309-8CD4-FB5B3E10EC3FQ34966336-85FD32E7-C070-4EDC-AC9C-D6835876026AQ34975833-B7597DBD-9C30-4840-8C31-7B423291E353Q34975960-3A489A44-7DAB-461E-B28E-712261BEE67F
P2860
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines
description
im Dezember 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 1997
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1997
@uk
name
A National Cancer Institute Wo ...... lights and Bethesda Guidelines
@en
A National Cancer Institute Wo ...... lights and Bethesda Guidelines
@nl
type
label
A National Cancer Institute Wo ...... lights and Bethesda Guidelines
@en
A National Cancer Institute Wo ...... lights and Bethesda Guidelines
@nl
prefLabel
A National Cancer Institute Wo ...... lights and Bethesda Guidelines
@en
A National Cancer Institute Wo ...... lights and Bethesda Guidelines
@nl
P2093
P2860
P356
P1476
A National Cancer Institute Wo ...... lights and Bethesda guidelines
@en
P2093
C R Boland
D E Henson
M A Rodriguez-Bigas
S R Hamilton
S Srivastava
P2860
P304
P356
10.1093/JNCI/89.23.1758
P407
P577
1997-12-01T00:00:00Z